SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-20-053946
Filing Date
2020-11-16
Accepted
2020-11-13 18:09:27
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 life-s3.htm S-3 612014
2 EX-4.8 life-ex48_9.htm EX-4.8 441213
3 EX-4.11 life-ex411_8.htm EX-4.11 133485
4 EX-4.12 life-ex412_6.htm EX-4.12 151908
5 EX-4.13 life-ex413_7.htm EX-4.13 110453
6 EX-5.1 life-ex51_47.htm EX-5.1 45551
7 EX-23.1 life-ex231_46.htm EX-23.1 2724
8 GRAPHIC geqauvxtfotb000001.jpg GRAPHIC 3541
9 GRAPHIC ge3cs4mppa5k000001.jpg GRAPHIC 28720
10 GRAPHIC geqauvxtfotb000002.jpg GRAPHIC 3541
  Complete submission text file 0001564590-20-053946.txt   1548096
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-250095 | Film No.: 201312973
SIC: 2836 Biological Products, (No Diagnostic Substances)